New Filings & Updated Terms (12.21.18-1.11.19)

NEW FILINGS

Company: Alector, Inc.
Symbol: ALEC
Description: They are a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen, Barclays
Filed: 1-7-19
Listed Cash Raise: $100m

Company: Anchiano Therapeutics Ltd.
Symbol: ANCN
Description: They are a clinical-stage biotechnology company committed to engineering a targeted gene therapy to improve the standard treatment for early-stage bladder cancer, which is one of the most prevalent forms of cancer. Their ordinary shares are listed on the Tel Aviv Stock Exchange Ltd., or the TASE, under the symbol “ANCN”.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Oppenheimer & Co.
Co-Manager(s): Ladenburg Thalmann
Filed: 1-7-19
Listed Cash Raise: $35m

Company: Exeter Finance Corporation
Symbol: XTF
Description: They are an industry leading, full-service, technology and data-driven specialty finance company, operating in the U.S. automobile finance market since April 2006.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Citigroup, Wells Fargo
Filed: 1-8-19
Listed Cash Raise: $100m

Company: Kaleido Biosciences, Inc.
Symbol: KLDO
Description: They are a clinical-stage healthcare company with a differentiated, chemistry-driven approach focused on leveraging the potential of the microbiome organ to treat disease and improve human health.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, J.P. Morgan, Morgan Stanley
Co-Manager(s): Canaccord Genuity
Filed: 1-11-19
Listed Cash Raise: $100m

Company: TCR2 Therapeutics Inc.
Symbol: TCRR
Description: They are an innovative immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Jefferies, Leerink, BMO Capital
Co-Manager(s): Wedbush Capital, China Renaissance
Filed: 12-28-18
Listed Cash Raise: $100m

Company: Futu Holdings Limited
Symbol: FHL
Description: They are an advanced technology company transforming the investing experience by offering a fully digitized brokerage platform.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, UBS, Credit Suisse
Filed: 12-28-18
Listed Cash Raise: $300m

Company: Harpoon Therapeutics, Inc.
Symbol: HARP
Description: They are a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Citigroup, SVB Leerink
Co-Manager(s): Canaccord Genuity, Wedbush PacGrow
Filed: 1-4-19
Listed Cash Raise: $86.25m

Company: Super League Gaming, Inc.
Symbol: SLGG
Description: They are a leading amateur esports community and content platform offering a personalized experience to the large and underserved global audience of 2.3 billion gamers, as estimated by NewZoo.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Northland Capital, Lake Street
Co-Manager(s): National Securities Corporation
Filed: 1-4-19
Listed Cash Raise: $25m

Company: Poseida Therapeutics, Inc.
Symbol: PSTX
Description: They are a clinical-stage biopharmaceutical company focused on leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving therapeutics for patients with high unmet medical need.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Citigroup, Credit Suisse, Wells Fargo
Filed: 1-4-19
Listed Cash Raise: $1155m

Company: Stealth BioTherapeutics Inc.
Symbol: MITO
Description: They are a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Jefferies, Evercore, BMO Capital
Co-Manager(s): Nomura
Filed: 12-28-18
Listed Cash Raise: $86.25m

Company: Gossamer Bio, Inc.
Symbol: GOSS
Description: They are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): BofA Merrill Lynch, Leerink, Barclays, Evercore ISI
Filed: 12-21-18
Listed Cash Raise: $264.5m